[1] 何士大.重视老年临床医学研究[J].北京医学,2014(10):781-782.
[2] Asvold BO, Bj?ro T, Nilsen TI, et al. Thyrotropin levels
and risk of fatal coronary heart disease: the HUNT study
[J]. Arch Intern Med, 2008,168(8):855-860.
[3] 牟英,刘云兵,龚倩.甲状腺功能减退与冠心病关联性的临床分析
[J].临床和实验医学杂志,2015,14(7):1411-1413.
[4] Miura S, Iitaka M, Suzuki S,et al. Decrease in semm
levels of thv. roid hormone in patients with coronary heart
disease [J].Endocr J,1996,43(6):657-663.
[5] Stuijver DJ, van Zaane B, Romualdi E,et al. The effect
of hyperthyroidism on procoagulant, anticoagulant and fibri-nolytic factors: A systematic review and meta-analysis [J].
Thromb Haemost,2012;108:1077-1088.
[6] Pretnar-Oblak J, Sebestjen M, Sabovic M. Statin treat-ment improves cerebral more than systemic endothelial dys-function in patients with arterial hypertension [J]. Am J
Hypertens,2008,21(6):674-678.
[7] 薛杰,曹小丽,姜宏,等.甲状腺影像报告与数据系统联合超声弹
性成像对甲状腺良恶性结节的诊断价值[J].中国医学影像学杂
志,2015(5):351-355.
[8] Han TW, Zhou SS, Li JT,et al. Homocysteine is associ-ated with the progression of non- culprit coronary lesions
in elderly acute coronary syndrome patients after percutane-ous coronary intervention [J]. J Geriatr Cardiol, 2016,13:
299-305.
[9] Klein I, Ojamaa K. Thyroid hormone and the cardiovascu-lar system [J]. N Engl J Med, 2001,344(7):501-509.
[10] Zargar AH, Ganie MA, Masoodi SR, et al. Prevalence
and pattern of sick euthyroid syndrome in acute and chron-ic non-thyroidal illness-its relationship with severity and
outcome of the disorder [J]. J Assoc Physicians India,
2004,52:27-31.
[11] Walsh JP, Bremner AP, Bulsara MK,et al. Subclinical
thyroid dysfunction as a risk factor for cardiovascular dis-ease [J]. Arch Intern Med, 2005,165(21):2467-2472.
[12] Iervasi G, Molinaro S, Landi P, et al. Association be-tween increased mortality and mild thyroid dysfunction in
cardiac patients [J]. Arch Intern Med, 2007,167(14):1526-1532.
[13] Tseng FY, Lin WY, Lin CC,et al. Subclinical hypothy-roidism is associated with increased risk for all-cause and
cardiovascular mortality in adults [J]. J Am Coll Cardiol,
2012,60(8):730-737.
[14] Tang YD, Kuzman JA, Said S,et al. Low thyroid func-tion leads To cardiac atrophy with chamber dilatation, im-paired myocardialblood flow, loss of arterioles, and severe
systolic dysfunction [J]. Circul, 2005,112(20):3122-3130.
[15] 赵翠,曹路,丛洪良,等.甲状腺功能正常者甲状腺激素水平与冠
心病发病的相关性分析[J].中华老年心脑血管病杂志, 2012,14
(4):358-360.
[16] Coceani M, Iervasi G, Pingitore A,et al. Thyroid hor-mone and coronary artery disease: from clinical correlations
to prognostic implications [J]. Clin Cardiol, 2009,32(7):
380-385.
[17] Pingitore A, Landi P, Taddei MC,et al. Triiodothyronine
levels for risk stratification of patients with chronic heart
failure [J]. Am J Med, 2005,118(2):132-136.
[18] lervasi G, Landi P, Raciti M, et al. Low-T3 syndrome:
astrong prognostic predictor of death in patients with heart
disease [J]. Circul,2003,107(5):708-713.
[19] 牟英,刘云兵,龚倩.甲状腺功能减退与冠心病关联性的临床分析
[J].临床和实验医学杂志,2015,14(7):1411-1413.